Navigation Links
Arteries from distinct regions of the body have unique immune functions
Date:9/3/2008

Human arteries play distinct roles in the immune system depending on their anatomical location, researchers at Emory University School of Medicine have discovered.

Their findings explain why vascular diseases affect different parts of the arterial network and could help doctors fine-tune the treatment of such diseases as atherosclerosis and vasculitis. Atherosclerosis causes heart attacks and strokes because it occurs preferentially in arteries supplying the heart and the brain.

The results were published online this week by the journal Circulation.

Arteries can play an active role in sensing foreign invasion and bodily injury, because cells embedded in the arterial walls called dendritic cells act like smoke-sensing fire alarms for the immune system, says senior author Cornelia Weyand, MD. PhD, co-director of the Kathleen B. and Mason I. Lowance Center for Human Immunology at Emory University.

"All of our major arteries have this alarm system," she says. "To our surprise, we found that the arteries of the neck, the arms, the abdomen and the legs are triggered by different infectious organisms. Thus, each artery functions in a specialized way."

Some vascular diseases attack arteries only in the abdomen or in the neck and upper extremities, and this selectivity has puzzled doctors for years, Weyand says.

To probe the differences among arteries, Weyand and her co-workers examined the activity of genes that encode Toll-like receptors in blood vessels from human donors.

Toll-like receptors are a cornerstone of the "innate" immune system, which can be activated by common features of infection-causing invaders. The capture of bacterial or viral fragments through Toll-like receptors alerts the immune system early during an infectious attack. Toll-like receptors can respond to whip-like antennas on bacteria called flagellae, parts of bacterial cell walls, or DNA and RNA that leaks from viruses or bac
'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
2. High-tech CT scans: not a bad choice to test for clogged arteries
3. New Computerized Scans Effective for Spotting Clogged Arteries
4. Super-Thin Drug-Free Coating Hides Stent as It Unblocks Heart Arteries
5. Drug-Coated Balloons Keep Leg Arteries Open: Study
6. Diabetes Drug Slows Clogging of Arteries
7. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
8. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
9. Gene screen patent leads to Deal of Distinction
10. Distinctive Art Auction Supports American Red Cross of Central New Jersey
11. Belief, disbelief and uncertainty activate distinct brain regions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , Sponsored by Merck, the unique online a...icipants in their HIV treatment decisions ,, A...- TheBody ( www.thebody.com ), the #1 HIV/AIDS res... online and mobile tool offering HIV/AIDS-infected...heir medical data. The tool, created with sponsors...
(Date:11/30/2009)... , Study Uses Tent To Si...EW YORK, Nov. 30 Distan...gen levels are known to improve their performance ... heart failure patients, who suffer from fatigue, ... tent-like, high-altitude simulator? ,, That is...
(Date:11/30/2009)... , NEW YORK, Nov. 30 O...tates who are living with HIV/AIDS, nearly half ar...on rates in Washington, D.C. have surpassed the th... Black women account for more than 90 percent of a...apitol. On Tuesday, December 1 at 6:00 p.m.*, Worl...
(Date:11/30/2009)...ere is a tiny period of time between the registrat...nd our conscious recognition of it ― between...e it as an apple. Our minds lag behind our eyes, b...ions to the world around us? , Some estimates ...hers say 500 milliseconds. A new study by Tel Aviv...
(Date:11/30/2009)... Keynote speaker & Author... , Corpus Christi, TX (Vo...Autism Conference is set to be held in Corpus Chr...ecember 5, 2009 at the American Bank Center., , ,...is expected to make a nearly $300,000 economic imp...
Breaking Medicine News(10 mins):Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:Now you see it, now you know you see it 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2
...Partner, Paladin, Enters Into Co- Pr...C, Feb. 1 /PRNewswire-FirstCall/ - Labopharm Inc. ...anadian licensing and distribution,partner for its...ada Inc. The agreement will double the number of p...
...y joy and goodwill that,epitomise Christmas and th...tions, letdowns, tension and, not least, drinking ... of the year for someone with alcohol,issues: offi... the merriment of Christmas and the New Year masks...
...ir Employee Health Benefit Plans Stack Up, PARSIP...ource executives grappling with ways to keep their...t effective found out how their plans,compare to o... Benefit Sources & Solutions in Bound Brook,presen...
...creased chances by 85%, study finds , , T...f sugar-sweetened soft drinks and fructose is stro..., a new study says. , Gout, caused by excess uric ...ates over the past few decades. , In this study, p...
...el drug romiplostim (Nplate) show that it signific...ronic immune thrombocytopenic purpura (ITP), a hem...ding. An international research team reports Phas... the February 2 issue of The Lancet. , Many ITP ...
...Office of Management and Budget evaluates research...ther federal agencies using the Program Assessment...agencies about many aspects of their programs, inc...effective, or somewhere in between. An "ineffecti...
Other Medicine News:Health News:Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly 2Health News:Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly 3Health News:A Festive White Knuckle Ride? 2Health News:Key to Attracting and Retaining Quality Employees: Benefits 2Health News:Key to Attracting and Retaining Quality Employees: Benefits 3Health News:Sugary Soft Drinks Boost Gout Risk in Men 2Health News:Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder 2Health News:Changes needed in how federal government evaluates efficiency of research at EPA, other agencies 2
(Date:11/30/2009)...-- Amoena USA Corporation, the worldwide leader of...the 4th Annual Breast Cancer Survivors Cruise. In ...ors and the people who helped them through their r...ost inspirational story to tell. ,, As part of ...ers who bravely endured treatments; women who, des...
(Date:11/30/2009)... 30 Optoacoustics has announced,av...phone, the most advanced,optical microphone availa...ng,(fMRI) environments. , The third gener...ber,optic microphone technology, providing the cle...ve noise cancelling. The FOMRI-III also introduces...
(Date:11/30/2009)...re/ -- Intelliject, Inc. today announced an exclus...pinephrine auto-injector, in the U.S. and Canada t...hall be responsible for manufacturing and commerci... on-going development and for obtaining U.S. regul...on rights in the territory. ,, Sanofi-aventis U...
Breaking Medicine Technology:Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 1FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 2FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 3FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 4FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 5UTMB study identifies women at risk of gaining excessive weight with injectable birth control 9351 1UTMB study identifies women at risk of gaining excessive weight with injectable birth control 9351 2Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 1Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 2Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 3
...sis of Pivotal Trial to Be Available No Later Than...asdaq:,FVRL), a biopharmaceutical company developi...e treatment of cancer, announced that an independe...ed to assess time to tumor,progression (TTP) for p...tal Phase 3 clinical trial of FavId(R). The DMB as...
...stent with MKC-1 Akt-mTOR Inhibitor Mechanism, RO...MD ), a clinical-stage pharmaceutical company deve...d inflammatory diseases, today,announced the prese...KC-1,in preclinical renal cell carcinoma (RCC) mod...RTC International Conference on Molecular,Targets ...
Other Medicine Technology:Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 2Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 3Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 4Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 5Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 6Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 7Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 8Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 9EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 2EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 3EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 4
Kelman-McPherson Angled Suturing-Corneal Forceps
Lieberman Suturing Forceps
Watzke Sleeve Spreading Forceps
Castroviejo Suture Forceps
Medicine Products: